Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.6100 (-3.28%) ($15.6100 - $15.6100) on Fri. Sep. 3, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.07% (three month average) | RSI | 80 | Latest Price | $15.6100(-3.28%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 11.5% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(45%) ARKK(45%) IBB(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.535% in a week (0% probabilities). VIXM(-37%) VXX(-27%) IGOV(-16%) UNG(-13%) USO(-10%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.535% (StdDev 3.07%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $15.43(1.17%) | 10 Day Moving Average | $14.72(6.05%) | 20 Day Moving Average | $13.65(14.36%) | To recent high | -5.8% | To recent low | 30% | Market Cap | $1.16b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |